Riskpilot← Back to searchSign inGet full accessTermino C 13459 AB
ABDissolvedOrg 5569439960General medical practice activities · NACE 8621Est. 20130 employees
Revenue 2024
SEK 1K
EBITDA margin
-3593.5%
+84% vs 2023
Equity ratio
80.0%
Financial strength
Net profit 2024
SEK -37K
+84% vs 2023
| Revenue | SEK 1K | — |
| EBITDA | SEK -39K | +84% |
| Net profit | SEK -37K | +84% |
| Total assets | SEK 300K | -1% |
| Equity | SEK 240K | -13% |
| Employees | 0 | — |
Legal name
Termino C 13459 AB
Org number
5569439960
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 oktober 2013
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget skall bedriva förvaltning av värdepapper samt därmed jämförlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 81 | 127 | 189 | 0 | 1 |
| Staff expenses | — | — | −77 | −49 | −0 |
| EBITDA | −563 | −55 | −2 173 | −241 | −39 |
| Depreciation & amort. | −21 | −12 | — | — | — |
| EBIT | −584 | −67 | −2 173 | −241 | −39 |
| Net financials | −1 | — | 0 | 2 | 2 |
| Profit before tax | 24 | 119 | −1 785 | −239 | −37 |
| Tax | −11 | −28 | −67 | −1 | — |
| Net profit | 13 | 91 | −1 852 | −240 | −37 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 202 | 4 204 | 900 | 302 | 300 |
| Equity | 2 277 | 2 369 | 517 | 277 | 240 |
| Long-term debt | 915 | 1 015 | 0 | — | — |
| Short-term debt | 435 | 432 | 383 | 25 | 60 |
| Total debt | 1 350 | 1 447 | 383 | 25 | 60 |
EBITDA margin
-3593.5%
This company
15.8%
Market median
-22844% vs market
20202024
Equity ratio
80.0%
This company
38.2%
Market median
+109% vs market
20202024
Return on equity
-15.6%
This company
18.4%
Market median
-185% vs market
20202024
Net profit margin
-3400.5%
This company
8.1%
Market median
-42081% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (4) | ||
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2022 – 2022 | |
| Chairman | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Termino C 13459 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Christina Qvarnström Jilke | Deputy Board Member | 0 companies |
| Anders Jakob Lindquist | Deputy Board Member | 0 companies |
| Torbjörn Nordberg | Board of Directors | 0 companies |
| Peter Zacarias Valfrid Jilke | Board of Directors | 0 companies |
| Jan-Eric Åkerlind | Board of Directors | 0 companies |
| Jan Peter Gustav Jilke | Chairman | 0 companies |